Lenalidomide Mylan

Medicinal product

(Invented) name

Lenalidomide Mylan

Active substance (s)

Lenalidomidas

Strength

20 mg

Pharmaceutical form

kietosios kapsulės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L04AX04, Lenalidomide

Marketing authorisation holder

Mylan Pharmaceuticals Limited, Airija

Date of authorisation

2020-12-18

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Hard capsule	1 vnt.
Lenalidomidas	20 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
105613	91713	1091713	lizdinė plokštelė	N7		Receptinis	EU/1/20/1490/013	Netiekiama	-	-	No	-	-
105614	91714	1091714	lizdinė plokštelė	N21		Receptinis	EU/1/20/1490/014	Netiekiama	-	-	No	-	-
105615	91715	1091715	dalomoji lizdinė plokštelė	N21×1		Receptinis	EU/1/20/1490/015	Netiekiama	-	-	No	-	-
106919	93022	1093022	dalomoji lizdinė plokštelė	N7×1		Receptinis	EU/1/20/1490/025	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2020-12-18	Registruotas